Análisis

Mounjaro drove over 30% growth in Korea's obesity treatment market in two months, while Wegovy sales fell for two consecutive months, dropping to fifth place.

Pharmacies report stockouts of pediatric oseltamivir suspension powder as influenza cases surge; some manufacturers still hold inventory, but supply pressure is rising.

Jongkundang is working to secure reimbursement for its domestically developed GI medication Zitec, with the National Health Insurance Service evaluating its clinical usefulness, industrial value, alternative drug pricing, and fiscal impact.

Korea Pfizer and Il Dong Pharmaceutical have signed a distribution and joint promotion agreement for the migraine drug Nutex oral disintegrating tablet, leveraging Il Dong's CNS sales expertise to accelerate market entry.

Analysis of 25,862 operating pharmacies shows a move from friendly names like 'Health' to business‑focused names such as '365' and 'Mega'.

Magmil tablets from Samnam Pharmaceutical recorded the highest number of out‑of‑stock restock requests in August, with 26,673 alerts, according to BRPConnect data.

After the 2025 OTC standard change, Hanmi and Dongkook launched ibuprofen‑combination cold medicines last winter, and this fall Chong Kun Dang and Dong‑A are entering, expanding market competition.

Korea’s bio‑health industry posted its highest August export ever, $1.41 billion, a 22.3% increase from last year, while cumulative 2026 exports reached $12.11 billion.

CGRP-based migraine therapies are rapidly entering the Korean market, offering injectable and oral options that diversify treatment beyond traditional CNS‑active drugs.

Dongkook Pharmaceutical’s dermal repair brand Madecaphamacia introduced the TECA Plus Formula Facial Repair Cream Light, featuring enhanced moisture, absorption, and added PDRN, available in ~6,000 Korean pharmacies.

Daewon Pharmaceutical will keep producing and supplying the cough expectorant Ko Daewon Jeong, aiming to maintain patient convenience and avoid prescribing confusion.

A 20‑pyeong pharmacy with 21 MKR monthly sales was priced at 750 MKR, while one with 30 MKR sales fetched 600 MKR, showing a shift from the usual 25‑30× sales rule.